Marcus Neuroscience Institute, part of Baptist Health, Now Offers High-Intensity Focused Ultrasound for Patients with Essential Tremor

Marcus Neuroscience Institute, part of Baptist Health South Florida, at Boca Raton Regional Hospital, is now treating patients with high-intensity focused ultrasound (HIFU) for those suffering from essential tremor.

The technology uses concentrated ultrasound waves to heat the brain tissue and block signals causing the tremor. Under MRI guidance, sound waves are precisely focused on the small spot in the brain considered to be responsible for causing the tremors. There is no incision or general anesthesia used during the treatment.

“We are pleased to be able to offer HIFU treatment at Marcus Neuroscience Institute and help those dealing with essential tremor, which may have impacted their routines and daily activities,” said Timothy Miller, M.D., neurosurgeon anddirector of functional neurosurgery at Marcus Neuroscience Institute. “By having the ability to now target and treat specific areas of the brain with precision, we can improve the quality of life for so many in our community, allowing them to regain control and confidence in their lives.”  

Some of the benefits of HIFU include the following:

Incisionless treatment.
Outpatient procedure.
No general anesthesia.
Immediate results on the treated hand.
Safe and effective with minimal side effects.

 

The ability to offer the HIFU treatment at Marcus Neuroscience Institute was made possible through philanthropy.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”